3min chapter

Breakpoints cover image

#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?

Breakpoints

CHAPTER

The Importance of Lena Capaver in HIV Treatment

The population for whom lena capaver and embolizumab have been approved is very small. We're talking about less than 1% of the HIV population in the United States. They stand out in our minds because they're very difficult to manage. As a result, there's very little use of ableizumab and lena capavers at this point.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode